In Case You Missed It: NACDS Health Care Outlook 2023 in Chain Drug Review
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
Inclusion of the INFORM Consumers Act marks a major bipartisan step toward curbing the organized retail crime networks jeopardizing Americans’ safety.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
From August 27-29, small, mid-size and large companies converged at the Boston Convention & Exhibition Center to collaborate, connect and foster strategic business partnerships.
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
With the 2022 NACDS Total Store Expo set to launch, the Boston Business Journal this morning published an op-ed authored by NACDS President & CEO Steven C. Anderson.
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
With only 25 in-district work days left in July and August, the pharmacy community continues its great work promoting pro-patient, pro-pharmacy policy priorities to Members of Congress and their staff via the NACDS RxIMPACT Pharmacy Tour Program.
On July 8, Florida Governor Ron DeSantis issued an Executive Order “to drive transparency in prescription costs for Floridians.
NACDS’ engagement on national issues of critical importance to the industry and the patients it serves continues to generate awareness among the broader national trade association community.